Food for thought
The words “diet” and “exercise” are synonymous with weight loss. Researchers now think that “pharmacotherapy” should be too.
Articles by Natalya Ortolano, PhD
CRISPR-edited white adipocytes effectively treat diabetes in mice
Implanting brown fat into mice fed a high fat diet helps them lose weight and become glucose tolerant. Will it do the same for humans?
A drug that effectively treats vitiligo
There are currently no FDA-approved drugs to treat vitiligo, an autoimmune disease that kills skin pigment cells. But a phase III study of a drug used to treat atopic dermatitis may be the first to get the FDA seal of approval.
Understudied antibodies against SARS-CoV-2 predict patient survival
COVID-19 researchers focus their studies on antibodies targeting exposed parts of SARS-CoV-2, but in a new study, a group of researchers showed that antibodies targeting proteins inside the virus are just as important for a robust immune response.
New monoclonal antibody therapeutics made straight from cancer patients’ blood
Some scientists use cancer patients as libraries for discovering novel immunotherapies.
A worldwide effort to bank patient DNA
Researchers around the world are on a mission to bank biological samples from millions of people. So far, these efforts have disclosed the effects of arsenic exposure on the genome, supported development of early cancer diagnostics, and even revealed the ideal timing for COVID-19 boosters.
A drug that protects against Alzheimer’s disease may help with Wolfram Syndrome
Wolfram Syndrome is a rare disease that causes a myriad of challenges, including deafness, diabetes, and depression. New research suggests that an agonist used to treat neurodegenerative disorders may help alleviate some of the symptoms.
Genetic discrimination and Snapchat
What do 23andMe and Snapchat have in common? They both collect very personal information about their users. Do the benefits outweigh the risks?
Digital technology reveals the secrets to treating neurological disorders
A biotech start-up teamed up with technology giants like Apple to continuously monitor people with Parkinson’s disease so that they could personalize their treatments in the clinic and the lab.
